Figure 2.
Time courses of the number of GCTs (a,c) and GCTs per 100 million population (b,d) in the United States, Germany, France, the United Kingdom, Korea, Japan, and China. a,b: data for phase 2; and c,d: data for phase 3 GCTs. GCTs: Global clinical trials.